Session 1196: Predictive Markers
Cochair(s): G de The, A Gazdar
Date: Mon 11 February 2002,
Time: 14:00 - 16:00
Location: Amphithéâtre Monod
Oral Presentations
| Time |
Number |
Title / Authors / Affiliations |
| 14:00 |
299 |
The predictive
power of premalignant lesions of the
stomach.
A Grace, C Gulmann, D Butler, M Leader, E Kay
Department of Pathology,
Royal College of Surgeons in Ireland, Dublin
Ireland |
| 14:15 |
300 |
Influence of PUFA
on a prospective cancer biomarker in feline
adipose
KE Saker, BE Cowing, JH Herbein
1VA-MD
Regional College of Veterinary Medicine, and Department
of Dairy Science, , 2VA-MD Regional College of
Veterinary Medicine, Virginia Tech, Blacksburg,
VA |
| 14:30 |
301 |
Oligoclonal
expansion of B cells in the livers of hepatitis C virus
infection may be associated with the development of
B-cell non-Hodgkin lymphomas.
J Murakami, Y Shimizu, Y Kashii, K Ebata, T Kato, A
Watanabe
Toyama Medical and
Pharmaceutical University, Toyama, Toyama
Japan |
| 14:45 |
302 |
Utilising the
comet assay for the detection of mouse models in a large
scale genetic screen to determine genetic components of
radiation sensitivity
CA Schindewolf, A Hartmann, HV Liebscher, W Frieauff, H
Fuchs, E Binder, F Ohl, D Soewarto, H Gomolka, T Jung, H
de Angelis
1Institute
for Experimental Genetics, 3Institute for
Biomathematics and Biometry; GSF Research Centre for
Health and Environment, Neuherberg, Germany,
2Novartis Pharma AG, Preclinical Safety,
Basel, Switzerland, 4Max-Planck-Institute of
Psychiatry, Munich, Germany, 5Institute for
Radiation Hygiene, Federal Office of Radiation
Protection, Neuherberg, Germany |
| 15:00 |
303 |
DNA repair gene
polymorphisms and adult acute myeloblastic leukaemia
risk
CH Seedhouse, EP Das-Gupta, M Lewis, NH Russell
Deparmtent of Academic
Haematology, Clinical Sciences Building, Nottingham, NG5
1PB |
| 15:15 |
304 |
Genomic analysis
of scirrhous gastric cancer in a young
adult
H Mita, F Itoh, M Toyota, K Imai
First Department of
Internal Medicine, School of Medicine, Sapporo Medical
University, Sapporo, Hokkaido Japan |
| 15:30 |
305 |
Molecular and
histopathologic predictors of distant failures in corpus
cancer
A Mariani, TJ Sebo, J Katzman, D Riehle, GL Keeney, KC
Podratz
Mayo Clinic, Rochester,
MN United States |
| 15:45 |
306 |
Relationship of
microvessel density and VEGF with dynamic MRI parameters
in breast cancer
O Nalcioglu, M-Y Su, J Fruehauf, Y-C Cheung, E Mechetner,
A Kyshtoobayeva, S-C Chen, S Hsueh, Y-L Wan
1John Tu
& Thomas Yuen Center for Functional Onco-Imaging,
University of California, Irvine, USA,
2Oncotech Inc. Irvine, USA, 3Linko
Chang Gung Memorial Hospital, Taiwan |
Poster Presentations
| Number |
Title / Authors / Affiliations |
| 307 |
Clinical
implications of p53 tumor suppressor gene alterations in
esophageal adenocarcinoma: results of a 10-year
prospective study
AG Casson, S Evans, A Gillis, GA Porter, PJ Veugelers, SJ
Darnton, DL Guernsey, P Hainaut
1Dalhousie
University, Halifax, Nova Scotia Canada,
2International Agency for Research on Cancer,
Lyon, France |
| 308 |
Bcl-2, bax, and
p53 immunohistochemical alternations as predictive
markers for radiotherapy in patients with localized
prostate cancer.
S Kariya, Y Ogawa, A Nishioka, M Furihata, K Kasahara, K
Inoue, T Shuin, S Yoshida
1Department
of Radiology, 22nd Department of Pathology,
3Department of Urology; Kochi Medical School,
Nankoku, Kochi, Japan |
| 309 |
*Microvascular
Changes During Inhibition of Colorectal Liver Metastases
by SMANCS/Lipiodol.
D Kuruppu, H Maeda, C Christophi, PE O'Brien
1Dept of
Surgery, Monash Medical School, Alfred Hospital, Japan, ,
2Dept of Microbiology, Kumamoto University
School of Medicine, Japan |
| 310 |
Immunohistochemical
expression of caveolin-1 as a marker for the biological
potential of renal cell carcinoma
H Sakai, K Takehara, S Koga, H Kanetake
Department of Urology,
Nagasaki University School of Medicine, Nagasaki,
Japan |
| 311 |
Cancer markers
shown to be a cause as well as a consequence of cancer
activity
MS Beljanski
Ingenieur d'etude au
CNRS, Scientific Attache, Molecular International
Research, Inc, New York, NY [ok] |
| 312 |
Factors of cancer
tolerance: increased prevalence of GSTM1 proficiency in
elderly tumour-free smokers and
non-smokers
EN Imyanitov, AV Togo, EV Belogubova, VG Lemehov, KP
Hanson
N.N. Petrov Institute of
Oncology, St.-Petersburg, Russia |
| 313 |
Susceptibility
genes for bladder cancer
S Horn, E Schnakenberg, R Werdin, K Dreikorn, W
Schloot
1AdnaGen AG,
Hannover-Langenhagen, Lower Saxony Germany,
2Urological Division, St. Jürgen Hospital of
Bremen, Germany, 3Center for Human Genetic and
Genetic Counselling, University of Bremen,
Germany |
| 314 |
Potential protein
markers in diagnosis and treatment of
B-CLL
M Rogalinska, J Blonski, M Hanausek, T Robak, ZM
Kilianska
1Department
of Cytobiochemistry, University of Lodz, Banacha 12/16,
Lodz, Poland, 2Department of Hematology,
Medical University of Lodz, Lodz, Poland, 3AMC
Cancer Research Center, Denver, USA |
| 315 |
Identification
and molecular characterization of NUCB2 as potential
gastric cancer antigen
Z Slucka, A Line, A Stengrevics, G Li, E Jankevics, RC
Rees
1Biomedical
Research and Study Centre, University of Latvia, Riga,
Latvia, 2Latvian Oncology Center, Riga,
Latvia, 3Department of Life Sciences,
Nottingham Trent University, Nottingham, UK |
| 316 |
The detection of
early p53 mutations in non-dysplastic Barrett's
tissues.
GJS Jenkins, SH Doak, AP Griffiths, JM Parry, JN
Baxter
1Molecular
Pathology Group, Swansea Clinical School, University of
Wales Swansea, , 2School of Biological
Sciences, University of Wales Swansea, ,
3Department of Pathology, Morriston
Hospital |
| 317 |
Characterization
of an estrogen-regulated growth factor in endometrial
cancer
MB Jones, A Houwink, WL Lingle, EC Kohn, A Berchuck, KC
Podratz, NJ Maihle
1Mayo Clinic,
Rochester, MN United States, 2National Cancer
Institute, Bethesda, MD United States, 3Duke
University Medical Center, Durham, NC United
States |
| 318 |
*Clinical impact
of circulating tumor cells (CTC) morphological and
molecular (ß catenin mutations) characterization in
patients with hepatocellular carcinoma
G Vona, L Estepa, D Damotte, F Capron, C Béroud, H
Fontaine, A Mineur, B Nalpas, H Zylberberg, D Franco, B
Lacour, S Pol, C Bréchot, P Paterlini-Bréchot
1INSERM U370,
Services, Paris, 2Biochimie, Hôpital Necker,
Paris, 3Hepatologie, Hôpital Necker, Paris,
4Anatomie-Pathologique, Hôpital Necker, Paris,
5Chirurgie Digestive, Hôpital A. Beclère,
Clamart, 6Anatomie-Pathologique, Hôpital A.
Beclère, Clamart |
| 319 |
p53 gene
alterations in lymph node-positive breast cancer patients
on adjuvant chemotherapy
M Brankovic-Magic, R Jankovic, Z Magic, B Cikota, S
Radulovic
1Institute
for Oncology and Radiology of Serbia, Belgrade,
Yugoslavia, 2Institute for Medical Research,
Belgrade, Yugoslavia |
| 320 |
Sarcolectin plays
a role in normal and malignant cell
growth
F Chany, C Chany
1Universite
Rene Descartes. Laboratoire des Interferons et de la
Sarcolectine, Paris Cedex 06, France, 2ADBEA,
Service de Chirurgie Ortbopedique, H6pital
Saint-Vincent-de-Paul, 82 Avenue Denfert Rocbereau,
3Beijing Chemical Reagent Institute,
Jiulongsham, East Suburb, Beijing China |
| 321 |
*Expression of
human Telomerase Reverse Transcriptase (hTERT) mRNA in
tumor cells from urine, as tumor marker for monitoring
both relapse and urothelial microdissemination in bladder
carcinoma
N álvarez, F árias, E Fernández, A Escudero, G Gómez, A
Gómez, MV Toledo, A Moyano, E Caso
1Laboratorio
de Oncología Molecular Aplicada. Servicio de Oncología
Médica, Hospital Ramón y Cajal. Madrid. Spain, ,
2Servicio de Urología, Hospital Ramón y Cajal.
Madrid. Spain |
| 322 |
Androgen-sensitive
prostate cancer is characterized by a lower malignant
potential
L Bonaccorsi
Department of Clinical
Physiopathology University of Florence Viale Pieraccini 6
I-50134 Florence, Italy |
| 323 |
The estimation of
adhesion molecules sICAM-1, sICAM-2, sVCAM-1, sCD44 ST,
sCD44 V5 and dendritic cells function in children with
malignancies
J Weclawek-Tompol, A Chybicka, B Rybka, R Ryczan, D
Noworolska, J Boguslawska-Jaworska
Department of Children
Hematology and Oncology, Medical University of Wroclaw,
Poland |
| 324 |
Mixed
myelodysplastic and myeloproliferative syndromes
(MDS-MPS), a new stem cell disorder.
R Neuwirtová, K Michalová, B Novotná
11st
Med.Clin. Dept.Clin.Hematol. Charles Univ.Hospital,
Prague, Czech Republic, 23rd Med.Clin.
Dept.Cytogenetics Charles Univ.Hospital, Prague, Czech
Republic, 3Inst.Exper.Medicine Academy Sci,
Prague, Czech Republic |
| 325 |
DNA content as a
possible marker of preneoplasia in renal cysts with
comparison of solid and cystic renal
cancer.
J Kovacs, E Szabo, A Varga, T Nemeth, S Gomba, J
Kappelmayer
Department of Pathology,
Department of Urology, and Department of Clinical
Biochemistry and Molecular Pathology, University of
Debrecen Medical and Health Science Center, Debrecen,
Hungary |
| 326 |
Prognosis value
of cytokine levels in response to chemotherapy in non
small cell lung cancer
BA Alvarez, A Valls, L Muñoz, O Rodríguez, C Jurado, R
Rodríguez, M Riera, G Reimers, S Fernández, B López
1Department
of Internal Medicine, Service of Oncolgy Medicine and
Department of Medicine, Service Internal Medicine, ,
2Hospital Universitario de Canarias. Tenerife.
Spain |
|
Site Contents
- The Journal
- CDP, a peer-refereed
bi-monthly on predictive and preventive oncology
- The Society
- The International Society for Preventive
Oncology
- Meetings
- Network and earn CME credits at our
international symposia.
|
